A massive Veterans Affairs study has confirmed that nicotinamide may offer real protection against skin cancer. Patients who took the vitamin B3 derivative saw notable reductions in new cancer cases—especially squamous cell carcinomas. The findings could shift clinical thinking toward earlier, preventive use of nicotinamide, though it showed less benefit for transplant patients.
